黄芪多糖联合顺铂对人肺腺癌A549细胞增殖的抑制作用及对Bax、Bcl-2、Caspase-3的影响

被引:0
作者
李蓉
机构
[1] 南华大学
关键词
黄芪多糖; 顺铂; 人肺腺癌A549细胞; 协同作用;
D O I
暂无
年度学位
2015
学位类型
硕士
导师
摘要
目的:以人肺腺癌A549细胞为研究对象,探讨黄芪多糖与顺铂对该细胞的增殖抑制、周期调控、诱导凋亡的影响,并对两药联合作用的机制进行了初步的研究,从而为非小细胞肺癌的化疗提供新的思路,为以后临床应用提供理论依据。方法:体外培养人肺腺癌A549细胞,取处于对数生长期的细胞进行实验,实验分四组:阴性对照组;黄芪多糖组;顺铂组;黄芪多糖+顺铂组。MTT法检测黄芪多糖、顺铂及两药联合对细胞的增殖影响,并用Q值公式评估两药联合的作用效果;流式细胞术检测药物对细胞周期及凋亡率的影响;RT-PCR技术检测凋亡相关蛋白Bcl-2、Bax、Caspase-3的m RNA表达水平;Western blot检测Bax、Bcl-2、Caspase-3的蛋白表达变化。结果:1、黄芪多糖、顺铂对人肺腺癌A549细胞增殖呈时间-浓度依赖抑制作用;联合用药的增殖抑制作用优于单一用药,两药联合作用表现为单纯相加。2、流式细胞术检测处理48h的A549细胞,黄芪多糖作用后可出现G1期细胞阻滞(P<0.01);顺铂作用后出现S期细胞阻滞(P<0.01);两药物联用将细胞阻滞于G1和S期(P<0.01)。黄芪多糖、顺铂均能诱导A549细胞凋亡,且同一作用时间两者联合的凋亡率高于单一用药(P<0.01)。3、黄芪多糖、顺铂均可促进人肺癌A549细胞Bax、Caspase-3 m RNA表达和抑制Bcl-2 m RNA表达,差异均有统计学意义(P<0.01)。与单一用药组比较,黄芪多糖及顺铂联合作用效果更强,差异均有统计学意义(P<0.01)。4、与阴性对照组比较,黄芪多糖、顺铂均可明显促进人肺癌A549细胞Bax、Caspase-3蛋白表达,而抑制Bcl-2蛋白表达;与单一药物组及阴性对照组比较,黄芪多糖与顺铂联合作用效果更强,差异均有统计学意义(P<0.01)。结论:黄芪多糖、顺铂具有抑制人肺腺癌A549细胞增殖及促进细胞凋亡的作用,两药联合效果明显增强。黄芪多糖协同顺铂促人肺腺癌A549细胞凋亡,其作用机制可能与下调Bcl-2表达、上调Bax表达、增强Caspase-3表达有关。
引用
收藏
页数:60
共 37 条
[1]
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[2]
Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice.[J].Bin Yang;Bing Xiao;Taoyu Sun.International Journal of Biological Macromolecules.2013,
[3]
Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells [J].
Florou, Dimitra ;
Patsis, Christos ;
Ardavanis, Alexandros ;
Scorilas, Andreas .
CANCER BIOLOGY & THERAPY, 2013, 14 (07) :587-596
[4]
The Changing Epidemic of Lung Cancer and Occupational and Environmental Risk Factors [J].
Dresler, Carolyn .
THORACIC SURGERY CLINICS, 2013, 23 (02) :113-+
[5]
Treatment of cervical vertebral (C1) metastasis of lung cancer with radiotherapy: A case report [J].
Ni, Xuefeng ;
Wu, Ping ;
Wu, Changping ;
Wu, Jianfeng ;
Ji, Mei ;
Gu, Xiaofang ;
Tian, Bo .
ONCOLOGY LETTERS, 2013, 5 (04) :1129-1132
[6]
Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival [J].
Guo, Li ;
Bai, Shu-Ping ;
Zhao, Ling ;
Wang, Xiao-Hong .
MEDICAL ONCOLOGY, 2012, 29 (03) :1656-1662
[7]
First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer A Systematic Review [J].
Goffin, John ;
Lacchetti, Christina ;
Ellis, Peter M. ;
Ung, Yee C. ;
Evans, William K. .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) :260-274
[8]
Protective Effect of Astragalus Polysaccharides on ATP Binding Cassette Transporter A1 in THP-1 Derived Foam Cells Exposed to Tumor Necrosis Factor-Alpha [J].
Wang, Yan-Fu ;
Yang, Xiao-Fang ;
Cheng, Bei ;
Mei, Chun-Li ;
Li, Qing-Xian ;
Xiao, Hua ;
Zeng, Qiu-Tang ;
Liao, Yu-Hua ;
Liu, Kun .
PHYTOTHERAPY RESEARCH, 2010, 24 (03) :393-398
[9]
Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism [J].
Mao, Xian-qing ;
Yu, Feng ;
Wang, Nian ;
Wu, Yong ;
Zou, Feng ;
Wu, Ke ;
Liu, Min ;
Ouyang, Jing-ping .
PHYTOMEDICINE, 2009, 16 (05) :416-425
[10]
Immunoregulatory and Anti-Tumor Effects of Polysaccharopeptide and Astragalus polysaccharides on Tumor-Bearing Mice [J].
Li Jin ;
Bao Yixi ;
Lam Waikei ;
Li Wenwen ;
Lu Fang ;
Zhu Xuan ;
Liu Jing ;
Wang Hongping .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2008, 30 (04) :771-782